hLAB specialises in comprehensive analysis of clinical trial samples to precisely quantify and characterise immune responses, driving drug product development forward with confidence.
Our services are designed to provide critical pharmacodynamic data, confirming mechanisms of action, assessing immunogenicity, and correlating immune responses with clinical outcomes. By reducing risk at key stages, we help to ensure the success of your research and development efforts.
With a team of highly skilled scientists and state-of-the-art technology, we run immunology assays 52 weeks a year, performing over 70,000 assays annually. The majority of our work is contracted by the top five global pharmaceutical companies to support their phase I, II, and III clinical studies. We are dedicated to providing rapid, high-quality results to drive innovation and support the development of new therapies.
Multiplex Cytokine & Chemokine Analysis: Our Meso Scale Discovery (MSD) platform enables simultaneous detection of cytokines and chemokines, offering unparalleled sensitivity and tailored immune monitoring.
ELISA: Our ELISA platform provides precise detection and quantification of proteins, antibodies, and biomarkers, supporting comprehensive immune monitoring with high sensitivity.
Our MNA services deliver precise quantification of neutralising antibodies, using advanced protocols to provide reliable assessments of viral neutralisation and immune response. hLAB’s team of expert virologists utilise traditional MNAs to deliver precise quantification of neutralising antibodies against a wide range of viruses.
hLAB's FRNA services provide a reliable and quantitative approach to measure neutralising antibodies against RSV, Influenza, hMPV, SARS-CoV-2, and more, supporting both research and clinical applications with robust results.
Our HAI assays offer a dependable method for quantifying Influenza-specific antibodies, with tailored protocols that ensure accuracy for the specific Influenza strain. As a trusted high-throughput partner, we deliver fast and reliable results within short timelines, supporting the critical needs of our client’s development programmes.
We have expertise in measuring antigen-specific T cells with precision using our highly sensitive ELISpot assays, customised to meet the unique needs of your study.
Our specialised PBMC isolation and cryopreservation services ensure sample integrity and consistency across studies. hLAB has experience with several different isolation protocols, our scientists have been qualified by top 10 pharma companies to process PMBCs in accordance with their specific isolation methodologies.
